AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35331179 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality pathology overall
Number of subjects: 138
Study 34369902 — intervention group
Group type: EXPERIMENTAL
Intervention: olanzapine (10 mg) + miricorilant (600 mg)
Number of subjects: 66
Study 34369902 — intervention group
Group type: COMPARATOR
Intervention: olanzapine (10 mg) + placebo
Number of subjects: 66
Study 33125405 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Gas Analysis (BGA) using ABL800 Flex analyzer® and GEM series®
Number of subjects: 963
Study 33125405 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Gas Analysis (BGA) using RapidPoint 500®
Number of subjects: 963
Study 33125405 — intervention group
Group type: COMPARATOR
Intervention: Smoker status
Number of subjects: 963
Study 33125405 — intervention group
Group type: COMPARATOR
Intervention: BMI
Number of subjects: 963
Study 33125405 — intervention group
Group type: COMPARATOR
Intervention: RBC transfusion
Number of subjects: 963
Study 33125405 — intervention group
Group type: COMPARATOR
Intervention: Statins
Number of subjects: 963
Study 33125405 — intervention group
Group type: COMPARATOR
Intervention: Beta blocker
Number of subjects: 963
Study 33125405 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative substitution of volume and other co-medications
Number of subjects: 963
Study 35777057 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed flap technique
Number of subjects: 8
Study 35777057 — intervention group
Group type: COMPARATOR
Intervention: Open flap technique
Number of subjects: 8
Study 33917058 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher boundary ambiguity
Number of subjects: 47
Study 33917058 — intervention group
Group type: EXPERIMENTAL
Intervention: Boundary ambiguity
Number of subjects: 47
Study 33917058 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall model for somatization
Number of subjects: 47
Study 33917058 — intervention group
Group type: EXPERIMENTAL
Intervention: Boundary ambiguity and missing family members
Number of subjects: 47
Study 33911859 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensifentrine 0.375 mg + tiotropium
Number of subjects: 416
Study 33911859 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensifentrine 3 mg + tiotropium
Number of subjects: 416
Study 33911859 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensifentrine 1.5 mg + tiotropium
Number of subjects: 416
Study 33911859 — intervention group
Group type: COMPARATOR
Intervention: Placebo + tiotropium
Number of subjects: 416
Study 33439085 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialised oral nutritional supplement (ONS) containing arginine and proline, high in vitamins A, C, E, zinc, and selenium, 200ml twice daily for four weeks.
Number of subjects: 30
Study 33439085 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 30
Study 33439085 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialised ONS (for patients with diabetes).
Number of subjects: 30
Study 33439085 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialised ONS (for patients without diabetes).
Number of subjects: 30
Study 32306982 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC ANSWERS intervention
Number of subjects: 200
Study 32306982 — intervention group
Group type: COMPARATOR
Intervention: Routine Veterans Health Administration (VHA) primary care
Number of subjects: 200
Study 34890830 — intervention group
Group type: EXPERIMENTAL
Intervention: Wood-based materials (lower thermal effusivity)
Number of subjects: 16
Study 34890830 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacquered solid wood
Number of subjects: 16
Study 34890830 — intervention group
Group type: EXPERIMENTAL
Intervention: Oak-based materials
Number of subjects: 16
Study 34890830 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface treatment of materials
Number of subjects: 16
Study 35690752 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model for overall survival (OS) based on seven independent predictors: age, degree of differentiation, T stage, chemotherapy, number of sampled lymph nodes, number of positive lymph nodes, and tumor size.
Number of subjects: 1250
Study 35690752 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model for cancer-specific survival (CSS) based on three independent predictors: T stage, chemotherapy, and tumor size.
Number of subjects: 1250
Study 35690752 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model for OS and CSS.
Number of subjects: 1250
Study 34229916 — intervention group
Group type: EXPERIMENTAL
Intervention: Less invasive surgery (LIS)
Number of subjects: 107
Study 33941083 — intervention group
Group type: EXPERIMENTAL
Intervention: Hatha Yoga
Number of subjects: 70
Study 33941083 — intervention group
Group type: COMPARATOR
Intervention: Routine prenatal care
Number of subjects: 70
Study 32169524 — intervention group
Group type: EXPERIMENTAL
Intervention: Social exclusion
Number of subjects: 40
Study 32169524 — intervention group
Group type: COMPARATOR
Intervention: Social inclusion/control
Number of subjects: 40
Study 35618855 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical aminophylline instillation (IVAI)
Number of subjects: 83
Study 35618855 — intervention group
Group type: COMPARATOR
Intervention: Balloon dilatation
Number of subjects: 83
Study 34033447 — intervention group
Group type: EXPERIMENTAL
Intervention: Premature infant oral motor intervention (PIOMI)
Number of subjects: 60
Study 32910555 — intervention group
Group type: EXPERIMENTAL
Intervention: Free Maternal and Child Health (FMCH) programme
Number of subjects: 584
Study 33616337 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet count assessment over 14 days
Number of subjects: 18
Study 33616337 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of outcomes classified by the modified Rankin Scale (mRS)
Number of subjects: 18
Study 33616337 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet aggregability assessment by multiple electrode aggregometry (MEA)
Number of subjects: 18
Study 32080862 — intervention group
Group type: EXPERIMENTAL
Intervention: Treprostinil iontophoresis (1 mg/mL hydrogel)
Number of subjects: 5
Study 32080862 — intervention group
Group type: COMPARATOR
Intervention: Placebo iontophoresis
Number of subjects: 5
Study 32080862 — intervention group
Group type: EXPERIMENTAL
Intervention: Treprostinil iontophoresis
Number of subjects: 5
Study 35725562 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and onsite mentorship
Number of subjects: 216
Study 35725562 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training or mentorship)
Number of subjects: 216
Study 34382846 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-hour turning schedule
Number of subjects: 44
Study 34382846 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-hour turning schedule
Number of subjects: 44
Study 34382846 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-hour turning schedule
Number of subjects: 44
Study 34919831 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin (300-400 μg/kg per day for 3 consecutive days) and dihydroartemisinin-piperaquine (dosage depending on body weight) plus standard control interventions
Number of subjects: 10638
Study 34919831 — intervention group
Group type: COMPARATOR
Intervention: Standard control interventions
Number of subjects: 10638
Study 34919831 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin and dihydroartemisinin-piperaquine
Number of subjects: 10638
Study 36335783 — intervention group
Group type: EXPERIMENTAL
Intervention: Regorafenib 160 mg QD (arm A)
Number of subjects: 299
Study 36335783 — intervention group
Group type: EXPERIMENTAL
Intervention: Regorafenib 120 mg QD (arm B)
Number of subjects: 299
Study 36335783 — intervention group
Group type: EXPERIMENTAL
Intervention: Regorafenib 160 mg QD 1 week on/1 week off (arm C)
Number of subjects: 299
Study 34817519 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic donor nephrectomy (Group 2)
Number of subjects: 60
Study 34817519 — intervention group
Group type: COMPARATOR
Intervention: Standard laparoscopic donor nephrectomy (Group 1)
Number of subjects: 60
Study 34817519 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic donor nephrectomy (Group 3)
Number of subjects: 60
Study 32668474 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy (median dose of 59.4Gy within 2 months after ESD)
Number of subjects: 70
Study 32668474 — intervention group
Group type: COMPARATOR
Intervention: Non-radiotherapy (regular follow-up only)
Number of subjects: 70
Study 34379996 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical dance training with 'Dance Central' game for Xbox 360® with Kinect, 3 sessions of 40 minutes each week for 12 weeks
Number of subjects: 46
Study 34379996 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintained usual activities of daily living)
Number of subjects: 46
Study 35139271 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.COV2.S (5×10^10 viral particles)
Number of subjects: 39185
Study 36377172 — intervention group
Group type: EXPERIMENTAL
Intervention: Listerine Cool Mint (alcohol-based mouthwash)
Number of subjects: 64
Study 36377172 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Plax (mouthwash)
Number of subjects: 64
Study 36377172 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinica (mouthwash)
Number of subjects: 64
Study 36377172 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 64
Study 36377172 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanocomposite (Z350XT)
Number of subjects: 64
Study 36377172 — intervention group
Group type: EXPERIMENTAL
Intervention: Microhybrid (P60)
Number of subjects: 64
Study 32554843 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation (WB-EMS)
Number of subjects: 29
Study 32554843 — intervention group
Group type: COMPARATOR
Intervention: Inactive control group (CON)
Number of subjects: 29
Study 35971138 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN)
Number of subjects: 80
Study 35971138 — intervention group
Group type: COMPARATOR
Intervention: Delayed enteral nutrition (DEN)
Number of subjects: 80
Study 35971138 — intervention group
Group type: COMPARATOR
Intervention: Both EEN and DEN
Number of subjects: 80
Study 33771149 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 98
Study 33771149 — intervention group
Group type: COMPARATOR
Intervention: Glibenclamide
Number of subjects: 98
Study 35851686 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-compassion intervention
Number of subjects: 101
Study 35851686 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive dissonance intervention
Number of subjects: 101
Study 35851686 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 101
Study 34857536 — intervention group
Group type: EXPERIMENTAL
Intervention: Boys with exon 8 skippable deletions
Number of subjects: 196
Study 34857536 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 196
Study 33803970 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified research methods for nutrition during pregnancy, infancy, and early childhood
Number of subjects: 0
Study 36111391 — intervention group
Group type: EXPERIMENTAL
Intervention: D-RVd
Number of subjects: 201
Study 36111391 — intervention group
Group type: COMPARATOR
Intervention: RVd
Number of subjects: 201
Study 34139269 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support cue (support figure)
Number of subjects: 0
Study 34139269 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo (ergogenic supplement)
Number of subjects: 0
Study 34139269 — intervention group
Group type: COMPARATOR
Intervention: Control (stranger cue)
Number of subjects: 0
Study 32766779 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy (3 sessions of physical therapy including desensitization maneuvers and tendon/nerve gliding exercise program)
Number of subjects: 120
Study 32766779 — intervention group
Group type: COMPARATOR
Intervention: Surgery (carpal tunnel release)
Number of subjects: 120
Study 36477716 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient Foley catheter (CF)
Number of subjects: 0
Study 36477716 — intervention group
Group type: COMPARATOR
Intervention: Inpatient Foley catheter (CF)
Number of subjects: 0
Study 33631943 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (2 sessions/week for 8 weeks)
Number of subjects: 78
Study 33631943 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (2 sessions/week for first 4 weeks) followed by intermittent theta burst stimulation (2 sessions/week for next 4 weeks)
Number of subjects: 78
Study 33613539 — intervention group
Group type: EXPERIMENTAL
Intervention: tCRM score for acute rejection (AR)
Number of subjects: 124
Study 33613539 — intervention group
Group type: EXPERIMENTAL
Intervention: tCRM score for borderline rejection (BL)
Number of subjects: 124
Study 33613539 — intervention group
Group type: EXPERIMENTAL
Intervention: tCRM score for stable biopsies
Number of subjects: 124
Study 33613539 — intervention group
Group type: COMPARATOR
Intervention: Comparison of tCRM scores between pathologists finding inflammation vs. disagreement
Number of subjects: 124
Study 33613539 — intervention group
Group type: COMPARATOR
Intervention: Comparison of tCRM scores between pathologists finding inflammation vs. both finding no inflammation
Number of subjects: 124
Study 33613539 — intervention group
Group type: COMPARATOR
Intervention: Overall significance among all histologic groups
Number of subjects: 124
Study 33613539 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model predicting graft inflammation
Number of subjects: 124
Study 35679656 — intervention group
Group type: COMPARATOR
Intervention: Air
Number of subjects: 480
Study 35679656 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline
Number of subjects: 480
Study 33069062 — intervention group
Group type: EXPERIMENTAL
Intervention: 53-gene prognostic score system
Number of subjects: 540
Study 33069062 — intervention group
Group type: COMPARATOR
Intervention: Other chemotherapies
Number of subjects: 540
Study 33572618 — intervention group
Group type: EXPERIMENTAL
Intervention: Early physiotherapy program (functional exercises, scar manual therapy, educational tips)
Number of subjects: 40
Study 33572618 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 40
Study 32483998 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative FiO2
Number of subjects: 373
Study 32483998 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative SpO2
Number of subjects: 373
Study 32483998 — intervention group
Group type: EXPERIMENTAL
Intervention: First intraoperative PaO2
Number of subjects: 373
Study 32483998 — intervention group
Group type: EXPERIMENTAL
Intervention: Second intraoperative PaO2
Number of subjects: 373
Study 32483998 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative PaO2
Number of subjects: 373
Study 32483998 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperoxaemia incidence (first ABG)
Number of subjects: 373
Study 32483998 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperoxaemia incidence (second ABG)
Number of subjects: 373
Study 32483998 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperoxaemia incidence (postoperative ABG)
Number of subjects: 373
Study 32483998 — intervention group
Group type: EXPERIMENTAL
Intervention: PaO2 >200 mmHg (first ABG)
Number of subjects: 373
Study 32483998 — intervention group
Group type: EXPERIMENTAL
Intervention: PaO2 >200 mmHg (second ABG)
Number of subjects: 373
Study 32483998 — intervention group
Group type: EXPERIMENTAL
Intervention: PaO2 >200 mmHg (postoperative ABG)
Number of subjects: 373
Study 33039585 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg twice daily
Number of subjects: 142
Study 33972647 — intervention group
Group type: EXPERIMENTAL
Intervention: LUCAS-2
Number of subjects: 20
Study 33972647 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study 32439008 — intervention group
Group type: EXPERIMENTAL
Intervention: Selatogrel 8 mg
Number of subjects: 47
Study 32439008 — intervention group
Group type: EXPERIMENTAL
Intervention: Selatogrel 16 mg
Number of subjects: 47
Study 36183482 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized nutrition intervention combined with telephone‐based education for 6 months
Number of subjects: 60
Study 36183482 — intervention group
Group type: COMPARATOR
Intervention: Routine care with telephone follow-up after 6 months
Number of subjects: 60
Study 32710658 — intervention group
Group type: EXPERIMENTAL
Intervention: HELP-LTC (n = 105)
Number of subjects: 219
Study 32710658 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 114)
Number of subjects: 219
Study 36480957 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Number of subjects: 120
Study 36480957 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised training
Number of subjects: 120
Study 36480957 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study 33960511 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodoa
Number of subjects: 0
Study 33960511 — intervention group
Group type: COMPARATOR
Intervention: Dopamine agonists
Number of subjects: 0
Study 33960511 — intervention group
Group type: COMPARATOR
Intervention: Monoamine oxidase type B inhibitors
Number of subjects: 0
Study 32404633 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 32
Study 32404633 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 32
Study 35172988 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior OAC use
Number of subjects: 4614
Study 35172988 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban (vs VKA) with prior OAC use
Number of subjects: 4614
Study 33740922 — intervention group
Group type: EXPERIMENTAL
Intervention: Equine-Assisted Activities (EAA), 40-minute sessions twice a week for 16 weeks.
Number of subjects: 46
Study 33740922 — intervention group
Group type: COMPARATOR
Intervention: Control group (daily life without special treatments).
Number of subjects: 46
Study 32605909 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose pembrolizumab (2 mg/kg amended to 200 mg) plus reduced-dose ipilimumab (1 mg/kg) every 3 weeks for four cycles, then pembrolizumab alone for up to 2 years
Number of subjects: 153
Study 32605909 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose pembrolizumab plus reduced-dose ipilimumab
Number of subjects: 153
Study 35078620 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram incorporating age, Charlson Comorbidity Index (CCI), serum albumin, sodium, and hemoglobin.
Number of subjects: 454
Study 35078620 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 454
Study 35078620 — intervention group
Group type: EXPERIMENTAL
Intervention: Charlson Comorbidity Index (CCI)
Number of subjects: 454
Study 35078620 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum albumin
Number of subjects: 454
Study 35078620 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium
Number of subjects: 454
Study 35078620 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin
Number of subjects: 454
Study 35078620 — intervention group
Group type: EXPERIMENTAL
Intervention: One-year mortality rate
Number of subjects: 454
Study 32796255 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE)
Number of subjects: 23
Study 32796255 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 23
Study 34872952 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization techniques
Number of subjects: 0
Study 34872952 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic variants influencing alcohol consumption or LDL levels
Number of subjects: 0
Study 32327398 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDIHEALTH
Number of subjects: 142
Study 32327398 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 142
Study 33176924 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented metal-ceramic crowns
Number of subjects: 72
Study 33176924 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented veneered zirconia crowns
Number of subjects: 72
Study 33176924 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented monolithic zirconia crowns
Number of subjects: 72
Study 33176924 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-cemented metal-ceramic crowns
Number of subjects: 72
Study 33176924 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-cemented veneered zirconia crowns
Number of subjects: 72
Study 33176924 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-cemented monolithic zirconia crowns
Number of subjects: 72
Study 33176924 — intervention group
Group type: EXPERIMENTAL
Intervention: Veneered zirconia after 20 hours of aging
Number of subjects: 72
Study 33176924 — intervention group
Group type: EXPERIMENTAL
Intervention: Monolithic zirconia after 20 hours of aging
Number of subjects: 72
Study 32306608 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery
Number of subjects: 192
Study 32306608 — intervention group
Group type: COMPARATOR
Intervention: Thoracoscopy-laparoscopy-assisted surgery
Number of subjects: 192
Study 33284959 — intervention group
Group type: EXPERIMENTAL
Intervention: Webinar group (Online presentation) - 260 subjects
Number of subjects: 791
Study 33284959 — intervention group
Group type: EXPERIMENTAL
Intervention: Face to Face lecture using PowerPoint presentation (F2F PP group) - 261 subjects
Number of subjects: 791
Study 33284959 — intervention group
Group type: COMPARATOR
Intervention: Control group (Only lecture) - 270 subjects
Number of subjects: 791
Study 35671231 — intervention group
Group type: EXPERIMENTAL
Intervention: BaSICS intervention (32-hour group-based intervention)
Number of subjects: 113
Study 35671231 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 113
Study 33095935 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting heart rate 70–74 beats/min
Number of subjects: 788
Study 33095935 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting heart rate 75–80 beats/min
Number of subjects: 788
Study 33095935 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting heart rate >80 beats/min
Number of subjects: 788
Study 33095935 — intervention group
Group type: EXPERIMENTAL
Intervention: Increment of 10 beats/min in resting heart rate among those with hypertension
Number of subjects: 788
Study 32819962 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 0